Cost effective vaccines and therapeutics based on theæAAVLP platform
Therapies for Sanfilippo (SF) Syndrome Type A and Type B.
Excessive menstrual bleeding treatments
Custom Proteoglycan Therapies
Food allergy therapies
Therapeutic solutions for respiratory diseases¾
Developing drugs to treat pain
AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects for patients ...
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
CNS/cancer therapeutics & diagnostics
Immune-tolerated therapeutic proteins
Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products
Relaxin hormone antagonists
Therapeutic foam technology
Treatment of TBI, Stroke, and Alzheimer_Ñés Disease, and other injuries to the brain
Treatments for oxidative stress related diseases
Developing therapeutics to address neurological disabilities like Alzheimers disease and Downs Syndrome.
Develops antibody-based therapeutics
Capillary Sealing Therapeutics
Therapeutics & Diagnostics targeting nf-P2X7
Determination of cellular susceptibility to treatments
Bioverativ will be an independent, publicly-traded, global biotechnology technology focused on the discovery, research, development and commercialization of therapies for hemophilia and other ...
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
Cancer Drug Discovery and Technology Transfer
Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, ...
Working to develop novel cannabinoid-based therapies.
Kidney Stone Treatments, Lab Services
Small Molecules, astaxanthin, inflammation treatment
Develops novel compounds for cancer treatment. The most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor.
Cellerant is developing novel innate and adaptive immunotherapies for oncology and blood-related disorders, including cell-based and antibody therapeutics.
Ear wax removal
Fibrodysplasia ossificans progressiva treatments
Autism and Fragile X Syndrome treatments
Corbus Pharmaceuticals is a clinical stage biopharmaceutical company focusing on rare, life-threatening, chronic inflammatory diseases. The Company's lead product candidate, Resunab, is a first- ...
CV Sciences produces both pharmaceuticals and consumer products. The Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. ...
Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody bispecifics and ProCAR-NK cell therapies based on Protease-Activated Antibodies, 'Probodies'
Small Molecules, Injectables
Chiral switching of existing therapies/candidates